Bone Biologics (BBLG) Prepaid Assets (2013 - 2026)
Bone Biologics (BBLG) posted quarterly Prepaid Assets of $10000.0 for Q4 2025, little changed year-over-year from $10000.0 in Q4 2024, and little changed quarter-over-quarter from $10000.0 in Q3 2025.
Analysis
Bone Biologics (BBLG) Prepaid Assets (2013 - 2026) Analysis & Trends
Bone Biologics (BBLG) has reported Prepaid Assets for 13 consecutive years, with $10000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets changed 0.0% year-over-year to $10000.0; the TTM figure through Dec 2025 stood at $10000.0 (changed 0.0% YoY), while the FY2025 annual figure was $10000.0, changed 0.0% from the prior year.
- Prepaid Assets was little changed at $10000.0 in Q4 2025 per BBLG's latest filing, from $10000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $615238.0 in Q2 2023 and bottomed at $10000.0 in Q4 2023.
- Historically, Prepaid Assets has averaged $148706.4 across 5 years, with a median of $18430.0 in 2024.
- Annual changes were most pronounced in 2023 — Prepaid Assets jumped 269.54% — and 2024, when it slumped 98.32%.
- Bone Biologics' Prepaid Assets stood at $49019.0 in 2021, then plunged by 74.54% to $12479.0 in 2022, then dropped by 19.87% to $10000.0 in 2023, then changed by 0.0% to $10000.0 in 2024, then changed by 0.0% to $10000.0 in 2025.
- Business Quant data shows BBLG's Prepaid Assets at $10000.0 in Q4 2025, $10000.0 in Q3 2025, and $10000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | 18,430.00 |
| Jun 30, 2024 | 18,430.00 |
| Mar 31, 2024 | 10,000.00 |
| Dec 31, 2023 | 711,194.00 |
| Sep 30, 2023 | 523,758.00 |
| Jun 30, 2023 | 615,238.00 |
| Mar 31, 2023 | 595,434.00 |
| Dec 31, 2022 | 956,925.00 |
| Sep 30, 2022 | 141,734.00 |
| Jun 30, 2022 | 204,359.00 |
| Mar 31, 2022 | 279,128.00 |
| Sep 30, 2021 | 49,019.00 |
| Jun 30, 2020 | 1,433.00 |
| Mar 31, 2020 | 4,532.00 |